Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension
warfain, hypertension, international normalized ratio, therapeutic window, clinical trials, pharmaco-genomics, CYP2C9*3
Abstract
Abstract not found
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
E. Ravina (2011) The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. 148.
The American Society of Health-System Pharmacists (2017) The American Society of Health-System Pharmacists. 2.
G. Lim (2017) Milestone 2: Warfarin: from rat poison to clinical use.
(2021) The Top 300 of 2019.
The American Society of Health-System Pharmacists (2011) The American Society of Health-System Pharmacists.
(2011) Warfarin diet: What foods should I avoid?.
J. Ansell, A. Jacobson, J. Levy, H. Völler, J. Hasenkam (2005) Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation" (PDF). 99(1), 37-45.
J. Levy, W. Ageno, N. Chan, M. Crowther, P. Verhamme, J. Weitz (2016) When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. 14(3), 623-627.
O. Macina, J. Schardein (2007) Warfarin". Human Developmental Toxicants. 193-194.
A. Holbrook, S. Schulman, D. Witt, P. Vandvik, J. Fish, M. Kovacs (2012) Evidencebased management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 152S-e184.
D. Garcia, M. Crowther, W. Ageno (2010) Practical management of coagulopathy associated with warfarin. 340(apr19 1), c1813-c1813. https://doi.org/10.1136/bmj.c1813
Deanna Brown, Eric Wilkerson, W. Love (2015) A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. 72(3), 524-534. https://doi.org/10.1016/j.jaad.2014.10.027
A. Camm, G. Lip, De Caterina, R. Savelieva, I. Atar, D. Hohnloser, S. (2012) (November 2012) "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association". 33(21), 2719-2747.
M. Shoeb, M. Fang (2013) Assessing bleeding risk in patients taking anticoagulants. 35(3), 312-319.
Meghan Elliott, Deborah Zimmerman, Rachel Holden (2007) Warfarin Anticoagulation in Hemodialysis Patients: A Systematic Review of Bleeding Rates. 50(3), 433-440. https://doi.org/10.1053/j.ajkd.2007.06.017
M. Fang, A. Go, Y. Chang, L. Borowsky, N. Pomernacki, N. Udaltsova, D. Singer (2011) A new risk scheme to predict warfarinassociated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. 58(4), 395-401.
Zhu Y, Shennan M, Reynolds KK, Johnson NA, Herrnberger MR, Valdes Jr (2007) Estimation of warfarin maintenance dose based on VKORC1 (−1639 G>A) and CYP2C9 genotypes.
Caldwell MD, Berg RL, Zhang KQ, Glurich I, Schmelzer JR, Yale SH Evaluation of genetic factors for warfarin dose prediction.
C. Kealey, Z. Chen, J. Christie, C. Thorn, A. Whitehead, M. Price Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.
Published
2022-09-05
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.